Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 5, Issue 2, 2018, Pages

  Hottinger, Andreas F ^a   De Micheli, Rita ^a   Guido, Vanessa ^a   Karampera, Alexandra ^a   Hagmann, Patric ^a   Du Pasquier, Renaud ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85044275643     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000439     Document Type: Short Survey

References (13)

1. Williams TJ, Benavides DR, Patrice KA, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 2016;73:928-933.
2. Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 2016;29:806-812.
3. Cuzzubbo S, Javeri F, Tissier M, et al. Neurological adverse events associated with immune checkpoint inhibitors: review of the literature. Eur J Cancer 2017;73:1-8.
4. Larkin J, Chmielowski B, Lao CD, et al. Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis. Oncologist 2017;22:709-718.
5. Royal RE, Levy C, Turner K, et al. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 2010;33:828-833.
6. Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol 2017;74:1216-1222.
7. Feng S, Coward J, McCaffrey E, Coucher J, Kalokerinos PO, Byrne K. Pembrolizumab induced encephalopathy: a review of neurological toxicities with immune checkpoint inhibitors. J Thorac Oncol 2017;12:1626-1635.
8. Schneider S, Potthast S, Komminoth P, Schwegler G, Böhm S. PD-1 checkpoint inhibitor associated autoimmune encephalitis. Case Rep Oncol 2017;10: 473-478.
9. Ito M, Fujiwara S, Fujimoto D, et al. Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient. Ann Oncol 2017;28:2318-2319.
10. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554.
11. Oyanguren B, Sánchez V, González FJ, et al. Limbic encephalitis: a clinicalradiological comparison between herpetic and autoimmune etiologies. Eur J Neurol 2013;20:1566-1570.
12. Keeley KA, Rivey MP, Allington DR. Natalizumab for the treatment of multiple sclerosis and Crohn disease. Ann Pharmacother 2005;39:1833-1843.
13. Lobb RR, Hemler ME. The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 1994;94:1722-1728.